The overall goal of these studies is to advance our understanding of the function of a pathogenic T cell response in autoimmunity and to define the structural parameters of the HLA-DR: peptidelig and that stimulates the pathogenic T cell response. Toward this goal, we have made several significant observations regarding the structure and function of the RA associated alleles HLA-DR1 and DR4 in the presentation of auto antigenic peptides. Using a humanized mouse model we have developed for the study of the model auto antigen type IIcollagen (CII), we have identified the CII immunodominant determinants presented by the DR1and DR4 class II molecules, defined the molecular interactions that occur during both the binding of this peptide by these DR molecules and the recognition of this complex by the T cell receptor, solved the crystal structure of HLA-DR1 complexed with the immunodominant CIIpeptide, and developed a means of identifying CII-specific autoimmune T cells ex vivo for highly specific, functional studies of these cells. Based on these data, the focus of this proposal is to investigate the structure-function relationship between the binding affinity of theCII peptide by the DR molecules and the effect of this binding affinity on the stimulation and function of the CII-specific autoimmune T cells. The central hypothesis that we are testing in this proposal is that the low affinity interaction of self peptides with MHC class II molecules induces significant changes in the conformation of the class II: peptide complex, and that this altered structure plays a major role in the stimulation and function of autoimmune T cells. The impact of these studies will be significant to autoimmunity in general in that they address a seminal question - how do MHC molecules mediate susceptibility to autoimmunity? In addition, these studies will identify the phenotype of the autoimmune T cells and the mechanisms by which they function in mediating disease, and will determine how an MHC: peptide low affinity autoimmune response differs from a high affinity foreign anti genresponse. The long term prospect of these studies is that they will provide us with new structural/functional concepts that can be targeted for the development of highly specific immunotherapies for autoimmunity.
There are more than 40 autoimmune diseases in which we know the susceptibility isassociated with the expression of specific HLA-DR class II genes. In these studies we will usethe humanized HLA-DR1 autoimmune arthritis mouse model to study the a pathogenicautoimmune T cell response. This autoimmune disease model is the most widely studiedmodel of rheumatoid arthritis (RA). Through the experiments in this proposal we will gain newinsight into the evolution of an autoimmune T cell response and how the structure of an HLADRmolecule complexed with an autoantigen dictates the function of these pathogenic T cells.It is our long term goal that these studies lead to the development of new highly specific meansof intervening in autoimmune responses, to eliminate the undesirable side effects of currentless specific treatments, and provide direct means of regulating autoimmune responses.VA Public
| Sandal, Indra; Karydis, Anastasios; Luo, Jiwen et al. (2016) Bone loss and aggravated autoimmune arthritis in HLA-DR?1-bearing humanized mice following oral challenge with Porphyromonas gingivalis. Arthritis Res Ther 18:249 |
| Miller, David C; Whittington, Karen B; Brand, David D et al. (2016) The CII-specific autoimmune T-cell response develops in the presence of FTY720 but is regulated by enhanced Treg cells that inhibit the development of autoimmune arthritis. Arthritis Res Ther 18:8 |
